Cumberland Pharmaceuticals (CPIX) Total Debt (2016 - 2025)
Historic Total Debt for Cumberland Pharmaceuticals (CPIX) over the last 16 years, with Q3 2025 value amounting to $5.2 million.
- Cumberland Pharmaceuticals' Total Debt fell 6743.19% to $5.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.2 million, marking a year-over-year decrease of 6743.19%. This contributed to the annual value of $15.3 million for FY2024, which is 1949.31% up from last year.
- Per Cumberland Pharmaceuticals' latest filing, its Total Debt stood at $5.2 million for Q3 2025, which was down 6743.19% from $5.2 million recorded in Q2 2025.
- In the past 5 years, Cumberland Pharmaceuticals' Total Debt registered a high of $20.0 million during Q1 2022, and its lowest value of $5.2 million during Q1 2025.
- Its 5-year average for Total Debt is $14.0 million, with a median of $15.0 million in 2021.
- Per our database at Business Quant, Cumberland Pharmaceuticals' Total Debt soared by 3571.43% in 2022 and then plummeted by 6743.19% in 2025.
- Quarter analysis of 5 years shows Cumberland Pharmaceuticals' Total Debt stood at $15.0 million in 2021, then rose by 8.0% to $16.2 million in 2022, then fell by 21.09% to $12.8 million in 2023, then increased by 19.49% to $15.3 million in 2024, then tumbled by 65.69% to $5.2 million in 2025.
- Its Total Debt stands at $5.2 million for Q3 2025, versus $5.2 million for Q2 2025 and $5.2 million for Q1 2025.